Gas in Liquid Advanced
Hillhurst’s proprietary GLASSTM platform enables novel uses of therapeutic gases that, up until now, have been limited by inhaled delivery. We’ve developed a unique pipeline of novel liquid therapeutic candidates intended to treat patients with sickle cell disease, Parkinson’s disease, and acute pain.
Commitment to Patients
We are committed to realizing the full medical potential of therapeutic gases for patients in need. Driven by a sense of urgency to treat debilitating diseases with limited treatment options, Hillhurst is enhancing the way therapeutic gases are delivered, unlocking new applications through the development of novel liquid medicines.
Drops and drugs for diabetic vison loss
Eye injections are the only way to treat diabetic retinopathy, but many refuse to get them. Now, eye drops ...
Hillhurst Bio Turns Gas from Poisonous to Therapeutic
When most people think of carbon monoxide, they envision odorless gas that can poison the body. For San Diego-based Hillhurst ...
Deadly gas could treat diabetic blindness, according to AU study
Carbon monoxide from engine exhaust kills hundreds of people each year. But a tiny controlled amount might be a potential ...